Carotid Artery Intima Media Thickness Can Predict the Response to Phosphodiesterase 5 Inhibitors in the Patients With Moderate Erectile Dysfunction
1 other identifier
observational
181
1 country
1
Brief Summary
The aim of the present study was to examine the relationship between degrees of erectile dysfunction and carotid artery intima media thickness (CIMT) and its effect on the medical treatment of this disease. Considering that there are vascular pathologies in the etiology, it is important to reveal vascular disorders with CIMT, which is a non-invasive, easily applicable method, and to use it in the grading and treatment of erectile dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFirst Submitted
Initial submission to the registry
December 26, 2022
CompletedFirst Posted
Study publicly available on registry
January 11, 2023
CompletedJanuary 12, 2023
January 1, 2023
2 years
December 26, 2022
January 11, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Coexistence of erectile dysfunction and increased CIMT
Association erectile dysfunction with CIMT measurement
2 years
Study Arms (2)
Control group
31 male volunteers who did not have erectile dysfunction
Patient group
150 patients with erectile dysfunction
Interventions
Carotid artery intima media thickness measurement with ultrasound
Eligibility Criteria
Patients over 40 years of age and under 70 years old with erectile dysfunction
You may qualify if:
- \. Patients over 40 years of age and under 70 years
You may not qualify if:
- Patients under 40 years of age and over 70 years old
- Patients whose consent can not be obtained
- Those with endocrine disease except type II diabetes mellitus
- Concomitant malignancy
- \. Psychiatric problems 7. Previous penile or pelvic surgery/trauma 8. Penile curvature / Peyronie's disease 9. Patients receiving treatment for erectile dysfunction 10. Chronic liver failure 11. Chronic kidney failure 12. Neurological disease 13. Patients with low testosteron level (≤300 ng/dL)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bursa Yuksek Ihtisas Training and Research Hospital
Bursa, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Urology Department
Study Record Dates
First Submitted
December 26, 2022
First Posted
January 11, 2023
Study Start
January 1, 2018
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
January 12, 2023
Record last verified: 2023-01